New cancer clinical trial: Trial Evaluating the Efficacy of CARBOPLATIN in Metastatic Prostate Cancer With Gene Alterations in the Homologous Recombination Pathway

Published on: August 29, 2018 at 12:00PM
Conditions:   Castration-resistant Prostate Cancer;   Metastasis
Intervention:   Drug: Carboplatin
Sponsors:   Centre Francois Baclesse;   GIRCI (French Interregional Group of Clinical Research and Innovation);   Ligue Contre le Cancer (French association Against Cancer)
Not yet recruiting
https://ift.tt/2ojAJ6u